<DOC>
	<DOCNO>NCT00700960</DOCNO>
	<brief_summary>This study conduct Europe . The aim observational study describe condition concomitant administration slow-acting insulin analogue oral antidiabetic ( OADs ) order improve blood glucose control type 2 diabetes .</brief_summary>
	<brief_title>Observational Study Describing Conditions Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents Type 2 Diabetes Blood Glucose Control</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Type 2 diabetes HbA1c level great 7 % despite treatment two ( three ) oral antidiabetic drug ( OADs ) optimal dose level Patient agree take part study capable complete selfquestionnaire . Hypersensitivity insulin one excipients Treatment insulin least 6 month Participant clinical trial diabetes entry observational study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>